Form 8-K
 
 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): September 12, 2011
Streamline Health Solutions, Inc.
(Exact name of registrant as specified in its charter)
         
Delaware   0-28132   31-1455414
         
(State or other jurisdiction
of incorporation)
  (Commission File Number)   (IRS Employer Identification No.)
     

10200 Alliance Road, Suite 200, Cincinnati, OH
   
45242-4716
     
(Address of principal executive offices)   (Zip Code)
Registrant’s telephone number, including area code: (513) 794-7100
(Former name or former address, if changed since last report.)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
o   Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 
o   Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 
o   Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 
o   Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
 


 

Item 2.02  
RESULTS OF OPERATIONS AND FINANCIAL CONDITION
On September 12, 2011, Streamline Health Solutions, Inc. (“Streamline Health”) issued the press release attached hereto as Exhibit 99.1, which press release contains financial information about Streamline Health’s second fiscal quarter ended July 31, 2011. The information hereunder shall not be deemed to be “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934 (the “Exchange Act”) or otherwise subject to the liabilities of that section, nor shall it be incorporated by reference into a filing under the Securities Act of 1933 or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.
Item 9.01  
FINANCIAL STATEMENTS AND EXHIBITS
(d) Exhibits
         
EXHIBIT      
NUMBER     DESCRIPTION
       
 
99.1    
Second Quarter Earnings News Release of Streamline Health Solutions, Inc. dated September 12, 2011.
SIGNATURES
Pursuant to the requirements of the Securities Act of 1934, registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
         
  Streamline Health Solutions, Inc.
 
 
Date: September 12, 2011  By:   /s/ Stephen H. Murdock    
    Stephen H. Murdock   
    Chief Financial Officer   

 

2


 

         
INDEX TO EXHIBITS
         
Exhibit No.     Description of Exhibit
       
 
99.1    
Second Quarter Earnings News Release of Streamline Health Solutions, Inc. dated September 12, 2011.

 

3

Exhibit 99.1
Exhibit 99.1
(STREAMLINE HEALTH LOGO)
News Release
Visit our web site at: www.streamlinehealth.net
     
COMPANY CONTACT:
  INVESTOR CONTACT:
Robert E. Watson
  Joe Diaz, Robert Blum or Joe Dorame
Chief Executive Officer
  Lytham Partners, LLC
(513) 794-7100
  (602) 889-9700
STREAMLINE HEALTH® SOLUTIONS REPORTS Q2 RESULTS
Cincinnati, Ohio — September 12, 2011 — Streamline Health Solutions, Inc. (Nasdaq: STRM) today announced financial results for the second quarter of fiscal year 2011, ended July 31, 2011.
Highlights for the quarter and the six-month period included:
    Recurring maintenance revenues improved by 16% over the prior comparable quarter;
 
    Recurring software-as-a-service (SaaS) revenues for the quarter increased 3% over the prior comparable quarter;
 
    New bookings for the quarter, excluding maintenance revenue, exceeded $1.8 million;
 
    Backlog at quarter end was $18.1 million;
 
    Adjusted EBITDA on a year-to-date basis increased 100%;
 
    In August 2011, St. Vincent’s Medical Center extended its agreement with Streamline Health’s strategic partner, GE Healthcare. Under the terms of the seven-year agreement, the healthcare system will be converting from a licensing model to Streamline Health’s SaaS model, and will upgrade to a new accessANYware version with additional HIM workflows;
Revenues for the second quarter totaled $4.1 million, compared to $4.7 million in the prior year second quarter, the decrease in revenue is primarily the result of two large proprietary license sales that were recognized in the second quarter of fiscal 2010, that did not have comparable sales in the current quarter.
Recurring revenues from maintenance contracts improved by 16% or $300,000 over the prior comparable second quarter. The increase is due to the continued revenue recognition from backlog, and the incremental maintenance revenues from systems sold in prior quarters for which maintenance periods commenced subsequent to their respective sales in prior quarters. SaaS revenues increased by $29,000 or 3% over the prior comparable quarter due to one large customer subscription sold in fiscal 2010 which reached go-live status in fiscal 2011.

 

 


 

Total operating expenses for the second quarter of fiscal 2011 were $4.1 million compared with $4.7 million in the comparable prior year quarter. This decrease of approximately $600,000 was the result of management’s action to implement more sustainable staffing levels, processes, and costs; these reductions coupled with decreased capitalized software amortization due to older assets becoming fully amortized subsequent to the first half of fiscal 2010.
As a result, the Company recorded a net loss for the second quarter ended July 31, 2011 of $7,000, or $0.00 per fully diluted share, compared with net loss of $76,000, or $0.01 per fully diluted share, for the prior year comparable quarter. Adjusted EBITDA* (a non-GAAP measure) for the quarter ended July 31, 2011 was $919,000, or $0.09 per fully diluted common share (adjusted), compared to $990,000, or $0.10 per fully diluted common share (adjusted) in the comparable prior quarter. A reconciliation table is provided below.
New bookings for the second quarter, excluding maintenance services, were $1.9 million, primarily consisting of SaaS term fees and professional services.
Backlog at July 31, 2011 was $18.1 million, compared with $18.9 million at July 31, 2010 and $17.6 million at January 31, 2011. The decrease in the current backlog reflects recognition of revenue from SaaS and maintenance contracts in the prior backlog and the addition to the backlog of new maintenance, software and professional services contracts sold in the quarters subsequent to July 31, 2010.
Robert E. Watson, president and chief executive officer of Streamline Health said, “While revenues are up slightly on a year-to-date basis, adjusted EBITDA for the six month period is up 100% versus the comparable period last year. That is meaningful progress despite the dual burden of high severance costs and the costs to bring on-board the appropriate executives and associates as we continue to reposition this company to achieve material annual growth rates consistent with other high growth healthcare information technology companies. As I’ve indicated previously this is a process and we are moving along that continuum at a consistent rate. I am pleased with the progress this new management team has made in the two quarters of its tenure.”
Mr. Watson continued, “We are also pleased with the transitioning of the University of Virginia Health System to a “direct client” of Streamline Health coupled with their purchase of additional workflow technology, and the transitioning of St. Vincent’s Medical Center from a maintenance client to a long term SaaS client. This strongly reflects the new commitment of our sales force to gain a deeper understanding of our clients and to present solutions on how we might better meet their needs. In conjunction with a strong focus on managing operating expenses, we are making meaningful progress in recalibrating Streamline Health to become a leading healthcare information technology company.”

 

2


 

* Non-GAAP Financial Measures
Streamline Health reports its financial results in accordance with generally accepted accounting principles in the United States (“GAAP”). Streamline Health’s management also evaluates and makes operating decisions using various other measures. One such measure is adjusted EBITDA, which is a non-GAAP financial measure. Streamline Health’s management believes that these measures provide useful supplemental information regarding the performance of Streamline Health’s business operations.
Streamline Health defines “adjusted EBITDA” as net earnings (loss) plus interest expense, tax expense, depreciation and amortization expense of tangible and intangible assets, and stock-based compensation expense. A table illustrating this measure is included in this publication.
Conference Call Information
The Company will conduct a conference call and webcast to review the results of the second quarter of fiscal 2011 today, September 12, 2011, at 4:30 p.m. ET.
Interested parties can access the call by dialing (877) 317-6789 or (412) 317-6789, or listen via a live Internet webcast, which can be found at www.streamlinehealth.net. A replay of the call will be available for 30 days by visiting www.streamlinehealth.net or by calling (877) 344-7529 or (412) 317-0088, access code 451358, through October 12, 2011.
About Streamline Health
Streamline Health is a leading provider of document workflow and document management solutions, applications and services that help strategic business partners and healthcare organizations improve operational efficiencies through business process optimization. The Company provides integrated tools and technologies for automating document-intensive environments, including document workflow, document management, e-forms, connectivity, optical character recognition (OCR), and business process integration.
The Company’s workflow-based services offer solutions to inefficient and labor-intensive healthcare business processes throughout the revenue cycle, such as chart coding, abstracting and completion, remote physician referral order processing, pre-admission registration scanning and signature capture, financial screening, perioperative processing, mitigation processing, secondary billing services, explanation of benefits processing, and release of information processing. The Company’s solutions also address the document workflow needs of the Human Resources and Supply Chain Management processes of the healthcare enterprise. All solutions are available through a software as a service (SaaS) model of delivery via the Company’s Remote Hosting Center that better matches customers’ capital or operating budget needs, or via a locally installed software licensing model.
Streamline Health’s solutions create a permanent document-based repository of historical health information that is complementary and can be seamlessly integrated with existing disparate clinical, financial and administrative information systems, providing convenient electronic access to multiple forms of patient information from any location through secure web-based access. These integrated solutions allow providers and administrators to link existing systems with documents, which can dramatically improve the availability of patient information while decreasing direct costs associated with document retrieval, work-in-process, chart processing, document retention, and archiving.

 

3


 

For additional information please visit our website at www.streamlinehealth.net.
Safe Harbor statement under the Private Securities Litigation Reform Act of 1995
Statements made by Streamline Health Solutions, Inc. that are not historical facts are forward-looking statements that are subject to risks and uncertainties. The forward looking statements contained herein are subject to certain risks, uncertainties and important factors that could cause actual results to differ materially from those reflected in the forward-looking statements, included herein. These risks and uncertainties include, but are not limited to, the impact of competitive products and pricing, product demand and market acceptance, new product development, key strategic alliances with vendors that resell the Company products, the ability of the Company to control costs, availability of products produced from third party vendors, the healthcare regulatory environment, potential changes in legislation, regulation and government funding affecting the healthcare industry, healthcare information systems budgets, availability of healthcare information systems trained personnel for implementation of new systems, as well as maintenance of legacy systems, fluctuations in operating results, effects of critical accounting policies and judgments, changes in accounting policies or procedures as may be required by the Financial Accountings Standards Board or other similar entities, changes in economic, business and market conditions impacting the healthcare industry, the markets in which the Company operates and nationally, and the Company’s ability to maintain compliance with the terms of its credit facilities, and other risks detailed from time to time in the Streamline Health Solutions, Inc. filings with the U. S. Securities and Exchange Commission. Readers are cautioned not to place undue reliance on these forward looking statements, which reflect management‘s analysis only as of the date hereof. The Company undertakes no obligation to publicly release the results of any revision to these forward-looking statements, which may be made to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events.
Financial Tables on Following Pages

 

4


 

STREAMLINE HEALTH SOLUTIONS, INC.
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
Three and Six Months Ended July 31,
(Unaudited)
                                 
    Three Months     Six Months  
    2011     2010     2011     2010  
Revenues:
                               
Systems sales
  $ 163,200     $ 960,880     $ 294,202     $ 1,111,318  
Services, maintenance and support
    3,069,869       2,830,935       6,153,830       5,374,510  
Software as a service
    912,864       884,662       1,837,923       1,734,665  
 
                       
Total revenues (1)
    4,145,933       4,676,477       8,285,955       8,220,493  
 
                       
 
                               
Operating expenses:
                               
Cost of systems sales
    627,550       780,506       1,168,502       1,518,395  
Cost of services, maintenance and support
    1,155,667       1,378,778       2,489,538       2,760,988  
Cost of software as a service
    417,868       472,098       854,291       929,126  
Selling, general and administrative
    1,582,532       1,505,863       3,247,193       3,203,440  
Product research and development
    342,157       567,147       759,931       1,037,318  
 
                       
Total operating expenses
    4,125,774       4,704,392       8,519,455       9,449,267  
 
                       
Operating income (loss)
    20,159       (27,915 )     (233,500 )     (1,228,774 )
Other income (expense):
                               
Interest expense
    (21,791 )     (34,001 )     (41,633 )     (56,336 )
Miscellaneous income (expenses)
    (311 )     (9,023 )     (5,266 )     42,786  
 
                       
Loss before income taxes
    (1,943 )     (70,939 )     (280,399 )     (1,242,324 )
Income tax (expense)
    (5,000 )     (5,000 )     (7,315 )     (10,000 )
 
                       
Net loss
  $ (6,943 )   $ (75,939 )   $ (287,714 )   $ (1,252,324 )
 
                       
Basic and diluted net earnings (loss) per common share
  $ (0.00 )   $ (0.01 )   $ (0.03 )   $ (0.13 )
 
                       
Number of shares used in basic and diluted per common share computation
    9,817,370       9,506,904       9,847,348       9,460,911  
 
                       
 
     
(1)   Software as a service was previously labeled “Application hosting services”, management determined that “Software as a service” more closely defines the Company’s service offering.

 

5


 

STREAMLINE HEALTH SOLUTIONS, INC.
CONDENSED CONSOLIDATED BALANCE SHEETS
Assets
                 
    (Unaudited)     (Audited)  
    July 31, 2011     January 31, 2011  
Current assets:
               
Cash and cash equivalents
  $ 577,885     $ 1,403,949  
Accounts receivable, net of allowance for doubtful accounts of $140,000 and $100,000, respectively
    2,151,458       2,620,756  
Contract receivables
    535,941       680,096  
Prepaid hardware and third party software for future delivery
    40,963       72,259  
Prepaid customer maintenance contracts
    925,667       794,299  
Other prepaid assets
    217,187       200,056  
Deferred income taxes
    167,000       167,000  
 
           
Total current assets
    4,616,101       5,938,415  
 
           
Property and equipment:
               
Computer equipment
    2,815,087       2,708,819  
Computer software
    2,037,063       1,947,135  
Office furniture, fixtures and equipment
    747,867       747,867  
Leasehold improvements
    639,864       639,864  
 
           
 
    6,239,881       6,043,685  
Accumulated depreciation and amortization
    (4,895,412 )     (4,517,860 )
 
           
 
    1,344,469       1,525,825  
 
           
Other assets:
               
Contract receivables, less current portion
    274,647       241,742  
Capitalized software development costs, net of accumulated amortization of $13,833,284 and $12,832,347, respectively
    7,965,127       7,575,064  
Other, including deferred taxes of $711,000, respectively
    738,475       734,376  
 
           
Total other assets
    8,978,249       8,551,182  
 
           
 
  $ 14,938,819     $ 16,015,422  
 
           
Liabilities and Stockholders’ Equity
                 
    (Unaudited)     (Audited)  
    July 31, 2011     January 31, 2011  
Current liabilities:
               
Accounts payable
  $ 752,454     $ 565,252  
Accrued compensation
    575,603       1,163,843  
Accrued other expenses
    285,215       480,422  
Capital lease obligation
    132,299       183,637  
Deferred revenues
    5,093,616       5,766,795  
 
           
Total current liabilities
    6,839,187       8,159,949  
 
           
Long-term liabilities:
               
Line of credit
    1,250,000       1,200,000  
Lease incentive liability, less current portion
    54,464       61,034  
 
           
Total liabilities
    8,143,651       9,420,983  
 
           
Stockholders’ equity:
               
Convertible redeemable preferred stock, $.01 par value per share, 5,000,000 shares authorized, no shares issued
           
Common stock, $.01 par value per share, 25,000,000 shares authorized, 10,053,979 and 9,856,517 shares issued and outstanding, respectively
    100,539       98,565  
Additional paid in capital
    37,461,711       36,975,242  
Accumulated deficit
    (30,767,082 )     (30,479,368 )
 
           
Total stockholders’ equity
    6,795,168       6,594,439  
 
           
 
  $ 14,938,819     $ 16,015,422  
 
           

 

6


 

STREAMLINE HEALTH SOLUTIONS, INC.
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
Six Months Ended,
(Unaudited)
                 
    July 31, 2011     July 31, 2010  
Operating activities:
               
Net loss
  $ (287,714 )   $ (1,252,324 )
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:
               
Depreciation and amortization
    1,391,822       1,708,706  
Loss on disposal of fixed asset
    26,667        
Stock-based compensation expense
    395,732       243,104  
Provision for accounts receivable
    40,000       50,000  
Change in assets and liabilities:
               
Accounts, contract and installment receivables
    540,548       (133,787 )
Other assets
    (121,302 )     (114,459 )
Accounts payable
    187,202       200,007  
Accrued expenses
    (790,017 )     (388,100 )
Deferred revenues
    (673,179 )     (328,530 )
 
           
Net cash provided by (used in) operating activities
    709,759       (15,383 )
 
           
 
Investing activities:
               
Purchases of property and equipment
    (236,196 )     (302,292 )
Capitalization of software development costs
    (1,391,000 )     (1,274,000 )
Other
          2,974  
 
           
Net cash used in investing activities
    (1,627,196 )     (1,573,318 )
 
           
 
               
Financing activities:
               
Net change under revolving credit facility
    50,000       1,100,000  
Proceeds from exercise of stock options and stock purchase plan
    92,711       127,391  
Payments on capital lease obligation
    (51,338 )     (83,289 )
 
           
Net cash provided by financing activities
    91,373       1,144,102  
 
           
Decrease in cash and cash equivalents
    (826,064 )     (444,599 )
Cash and cash equivalents at beginning of period
    1,403,949       1,025,173  
 
           
Cash and cash equivalents at end of period
  $ 577,885     $ 580,574  
 
           
Supplemental cash flow disclosures:
               
Interest paid
  $ 29,621     $ 30,664  
 
           
Income taxes paid
  $ 16,957     $ 16,534  
 
           

 

7


 

STREAMLINE HEALTH SOLUTIONS, INC.
Backlog
(Unaudited)
Table A
Backlog (in thousands)
                         
    July 31, 2011     January 31, 2011     July 31, 2010  
Streamline Health Software Licenses
  $ 51,000     $ 121,000     $ 174,000  
Custom Software
    29,000       42,000       62,000  
Hardware and Third Party Software
    152,000       66,000       95,000  
Professional Services
    4,573,000       4,629,000       3,981,000  
Software as a service
    7,275,000       7,362,000       8,818,000  
Recurring Maintenance
    6,009,000       5,384,000       5,788,000  
 
                 
Total
  $ 18,089,000     $ 17,604,000     $ 18,918,000  
 
                 

 

8


 

STREAMLINE HEALTH SOLUTIONS, INC.
Bookings
(Unaudited)
Table B
New bookings (a)
                 
    Three Months Ended  
    July 31, 2011  
    Value     % of Total Bookings  
Streamline Health Software licenses
  $       0 %
Software as a service
    980,000       52 %
Professional services
    792,000       42 %
Hardware & third party software
    110,000       6 %
 
           
Total bookings
  $ 1,882,000       100 %
 
           
                 
    Six Months Ended  
    July 31, 2011  
    Value     % of Total Bookings  
Streamline Health Software licenses
  $       0 %
Software as a service
    1,067,000       40 %
Professional services
    1,358,000       51 %
Hardware & third party software
    232,000       9 %
 
           
Total bookings
  $ 2,657,000       100 %
 
           
     
(a)   Bookings are the aggregate of signed contracts and/or completed customer purchase orders approved and accepted by the Company as binding commitments to purchase its products and/or services. New bookings do not include maintenance services as these tend to be recurring in nature on an annual or more frequent basis.

 

9


 

STREAMLINE HEALTH SOLUTIONS, INC.
Reconciliation of Non-GAAP Financial Measures
(Unaudited)
Table C
This press release contains a non-GAAP financial measure under the rules of the U.S. Securities and Exchange Commission for adjusted EBITDA. This non-GAAP information supplements and is not intended to represent a measure of performance in accordance with disclosures required by generally accepted accounting principles. Non-GAAP financial measures are used internally to manage the business, such as in establishing an annual operating budget. Non-GAAP financial measures are used by Streamline Health’s management in its operating and financial decision-making because management believes these measures reflect ongoing business in a manner that allows meaningful period-to-period comparisons. Accordingly, the Company believes it is useful for investors and others to review both GAAP and non-GAAP measures in order to (a) understand and evaluate current operating performance and future prospects in the same manner as management does and (b) compare in a consistent manner the company’s current financial results with past financial results. The primary limitations associated with the use of non-GAAP financial measures are that these measures may not be directly comparable to the amounts reported by other companies and they do not include all items of income and expense that affect operations. The Company’s management compensates for these limitations by considering the company’s financial results and outlook as determined in accordance with GAAP and by providing a detailed reconciliation of the non-GAAP financial measures to the most directly comparable GAAP measures in the tables attached to this press release.
Reconciliation of net earnings(loss) to non-GAAP adjusted EBITDA (in thousands)
                                 
    Three Months Ended,     Six Months Ended,  
Adjusted EBITDA Reconciliation   July 31, 2011     July 31, 2010     July 31, 2011     July 31, 2010  
Net loss
  $ (7 )   $ (76 )   $ (288 )   $ (1,252 )
Interest expense
    22       34       42       56  
Tax expenses
    5       5       7       10  
Depreciation and other amortization
    193       233       391       455  
Amortization of capitalized software development costs
    507       639       1,001       1,254  
 
                       
EBITDA
    720       835       1,153       523  
 
                       
Stock-based compensation expense
    199       155       396       243  
 
                       
Adjusted EBITDA
  $ 919     $ 990     $ 1,549     $ 766  
 
                       
Capitalized software development costs
    606       578       1,391       1,274  
Adjusted EBITDA, less capitalized software development costs
    313       412       158       (508 )
 
                       
Adjusted EBITDA Margin
    22 %     21 %     19 %     9 %
 
                       
Adjusted EBITDA per diluted share
                               
Earnings (loss) per share — diluted
  $ (0.00 )   $ (0.01 )   $ (0.03 )   $ (0.13 )
Interest expense (1)
    0.00       0.00       0.00       0.00  
Tax expenses (1)
    0.00       0.00       0.00       0.00  
Depreciation and other amortization (1)
    0.02       0.02       0.04       0.05  
Amortization of capitalized software development costs (1)
    0.05       0.07       0.10       0.13  
Stock-based compensation expense (1)
    0.02       0.02       0.04       0.03  
 
                       
Adjusted EBITDA per adjusted diluted share
  $ 0.09     $ 0.10     $ 0.15     $ 0.08  
 
                       
Diluted weighted average shares
    9,817,370       9,506,904       9,847,348       9,460,911  
Includable incremental shares — adjusted EBITDA (2)
    12,715       19,336       17,951       19,336  
 
                       
Adjusted diluted shares
  $ 9,830,085     $ 9,526,240       9,865,299       9,480,247  
 
                       
     
(1)   Per adjusted diluted weighted average shares
 
(2)   The number of incremental shares that would be dilutive under profit assumption, only applicable under a GAAP net loss. If GAAP profit is earned in the current period, no additional incremental shares are assumed. If negative adjusted EBITDA is incurred, no additional incremental shares are assumed for adjusted diluted shares.

 

10